Dr. Grosen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 W 8th Ave
Spokane, WA 99204Phone+1 509-474-2200
Education & Training
- University of California (Irvine)Fellowship, Gynecologic Oncology, 1991 - 1994
- University of Arizona College of Medicine-TucsonResidency, Obstetrics and Gynecology, 1986 - 1990
- Huron HospitalResidency, Surgery, 1984 - 1986
- University of Washington School of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 1990 - Present
- MT State Medical License 2021 - 2025
- WA State Medical License 2000 - 2024
- WI State Medical License 1994 - 2003
- AZ State Medical License 1987 - 1995
- OH State Medical License 1985 - 1988
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 74 citationsPhase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.Jonathan Oh, Minal A. Barve, Carolyn M. Matthews, E. Colin Koon, Thomas P. Heffernan
Gynecologic Oncology. 2016-12-01 - 68 citationsGemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.Rodney P. Rocconi, Elizabeth A. Grosen, Sharad A. Ghamande, John K. Chan, Minal A. Barve
The Lancet. Oncology. 2020-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: